{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:39:17Z","timestamp":1792636757829,"version":"4.5.0"},"reference-count":15,"publisher":"Massachusetts Medical Society","issue":"6","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2026,2,5]]},"DOI":"10.1056\/nejmoa2510310","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T08:15:20Z","timestamp":1760861720000},"page":"563-575","source":"Crossref","is-referenced-by-count":42,"title":["Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer"],"prefix":"10.1056","volume":"394","author":[{"given":"Neal D.","family":"Shore","sequence":"first","affiliation":[{"name":"START Carolinas, Myrtle Beach, SC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murilo de Almeida","family":"Luz","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology, Erasto Gaertner Hospital, Curitiba, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"De Giorgi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gleave","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey T.","family":"Gotto","sequence":"additional","affiliation":[{"name":"Southern Alberta Institute of Urology, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Pieczonka","sequence":"additional","affiliation":[{"name":"Clinical Research, U.S. Urology Partners and Associated Medical Professionals of New York, Syracuse"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel P.","family":"Haas","sequence":"additional","affiliation":[{"name":"Oncology Global Development, Astellas Pharma, Northbrook, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choung-Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Urology, Ewha Womans University Mokdong Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Ramirez-Backhaus","sequence":"additional","affiliation":[{"name":"Servicio de Urolog\u00eda, Fundaci\u00f3n Instituto Valenciano de Oncolog\u00eda, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Rannikko","sequence":"additional","affiliation":[{"name":"Department of Urology and Research Program in Systems Oncology, University of Helsinki, Helsinki"},{"name":"Helsinki University Hospital, Helsinki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matko","family":"Kalac","sequence":"additional","affiliation":[{"name":"Oncology Division, Pfizer, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Sridharan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Calvary Mater Newcastle, Waratah, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Rosales","sequence":"additional","affiliation":[{"name":"Oncology Global Development, Astellas Pharma, Northbrook, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Tang","sequence":"additional","affiliation":[{"name":"Oncology Division, Pfizer, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ronald F.","family":"Tutrone","sequence":"additional","affiliation":[{"name":"Chesapeake Urology Research Associates, Towson, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Venugopal","sequence":"additional","affiliation":[{"name":"Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, United Kingdom"},{"name":"University of Glasgow, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnauld","family":"Villers","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Lille, Claude Huriez Hospital, Centre Hospitalier Universitaire Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4099-0339","authenticated-orcid":false,"given":"Henry H.","family":"Woo","sequence":"additional","affiliation":[{"name":"Department of Urology, Blacktown and Mount Druitt Hospitals, Blacktown, NSW, Australia"},{"name":"Department of Uro-Oncology, Chris O\u2019Brien Lifehouse, Camperdown, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong","family":"Wang","sequence":"additional","affiliation":[{"name":"Oncology Division, Pfizer, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8104-6419","authenticated-orcid":false,"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[{"name":"Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars\u2013Sinai Medical Center, Los Angeles"},{"name":"Durham Veterans Affairs Administration Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.4.433"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.0572"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303974"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300251"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.02.006"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.52971"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00799"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30587"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00193"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.5005"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2003892"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.17_suppl.LBA5004"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00197-4"},{"key":"e_1_3_5_15_2","first-page":"TPS5131","article-title":"Darolutamide plus androgen deprivation therapy (ADT) in patients with high-risk biochemical recurrence (BCR) of prostate cancer: a phase 3, randomized, double-blind, placebo-controlled study (ARASTEP).","volume":"43","author":"Morgans AK","year":"2025","unstructured":"Morgans AK, Niazi T, Shore ND, et al. Darolutamide plus androgen deprivation therapy (ADT) in patients with high-risk biochemical recurrence (BCR) of prostate cancer: a phase 3, randomized, double-blind, placebo-controlled study (ARASTEP). J Clin Oncol 2025;43:TPS5131-TPS5131 (https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2025.43.16_suppl.TPS5131).","journal-title":"J Clin Oncol"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00730-7"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2510310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T22:00:25Z","timestamp":1770242425000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2510310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,2,5]]}},"alternative-id":["10.1056\/NEJMoa2510310"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2510310","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}